JP2016196492A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016196492A5 JP2016196492A5 JP2016124235A JP2016124235A JP2016196492A5 JP 2016196492 A5 JP2016196492 A5 JP 2016196492A5 JP 2016124235 A JP2016124235 A JP 2016124235A JP 2016124235 A JP2016124235 A JP 2016124235A JP 2016196492 A5 JP2016196492 A5 JP 2016196492A5
- Authority
- JP
- Japan
- Prior art keywords
- atoms
- substituted
- unsubstituted
- het
- pyridyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161488997P | 2011-05-23 | 2011-05-23 | |
| US61/488,997 | 2011-05-23 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014512837A Division JP6054954B2 (ja) | 2011-05-23 | 2012-04-11 | ピリジン−及びピラジン誘導体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018061990A Division JP6763904B2 (ja) | 2011-05-23 | 2018-03-28 | ピリジン−及びピラジン誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016196492A JP2016196492A (ja) | 2016-11-24 |
| JP2016196492A5 true JP2016196492A5 (enExample) | 2017-12-07 |
Family
ID=45976540
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014512837A Expired - Fee Related JP6054954B2 (ja) | 2011-05-23 | 2012-04-11 | ピリジン−及びピラジン誘導体 |
| JP2016124235A Pending JP2016196492A (ja) | 2011-05-23 | 2016-06-23 | ピリジン−及びピラジン誘導体 |
| JP2018061990A Expired - Fee Related JP6763904B2 (ja) | 2011-05-23 | 2018-03-28 | ピリジン−及びピラジン誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014512837A Expired - Fee Related JP6054954B2 (ja) | 2011-05-23 | 2012-04-11 | ピリジン−及びピラジン誘導体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018061990A Expired - Fee Related JP6763904B2 (ja) | 2011-05-23 | 2018-03-28 | ピリジン−及びピラジン誘導体 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9273029B2 (enExample) |
| EP (1) | EP2714677B1 (enExample) |
| JP (3) | JP6054954B2 (enExample) |
| KR (1) | KR101581522B1 (enExample) |
| CN (1) | CN103748086B (enExample) |
| AU (1) | AU2012259333B2 (enExample) |
| BR (1) | BR112013029640A2 (enExample) |
| CA (1) | CA2832605C (enExample) |
| DK (1) | DK2714677T3 (enExample) |
| EA (1) | EA023364B1 (enExample) |
| ES (1) | ES2699256T3 (enExample) |
| HR (1) | HRP20181884T1 (enExample) |
| IL (1) | IL229528A (enExample) |
| LT (1) | LT2714677T (enExample) |
| MX (1) | MX352975B (enExample) |
| PL (1) | PL2714677T3 (enExample) |
| PT (1) | PT2714677T (enExample) |
| RS (1) | RS58015B1 (enExample) |
| SG (1) | SG194105A1 (enExample) |
| SI (1) | SI2714677T1 (enExample) |
| WO (1) | WO2012161877A1 (enExample) |
| ZA (1) | ZA201307429B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013029640A2 (pt) * | 2011-05-23 | 2017-06-13 | Merck Patent Gmbh | derivados de piridina e pirazina |
| GB201303109D0 (en) | 2013-02-21 | 2013-04-10 | Domainex Ltd | Novel pyrimidine compounds |
| PT3030554T (pt) * | 2013-08-07 | 2018-05-28 | Merck Patent Gmbh | Derivados de ureia de piperidina |
| US9908872B2 (en) | 2013-12-13 | 2018-03-06 | Dana-Farber Cancer Institute, Inc. | Methods to treat lymphoplasmacytic lymphoma |
| JP6879740B2 (ja) | 2013-12-13 | 2021-06-02 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | リンパ形質細胞性リンパ腫を処置する方法 |
| EP3105225A1 (en) | 2014-02-12 | 2016-12-21 | iTeos Therapeutics | Novel 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use |
| WO2015173764A1 (en) | 2014-05-15 | 2015-11-19 | Iteos Therapeutics | Pyrrolidine-2,5-dione derivatives, pharmaceutical compositions and methods for use as ido1 inhibitors |
| TW201613916A (en) | 2014-06-03 | 2016-04-16 | Gilead Sciences Inc | TANK-binding kinase inhibitor compounds |
| JP6499282B2 (ja) | 2014-09-26 | 2019-04-10 | ギリアード サイエンシーズ， インコーポレイテッド | Ｔａｎｋ結合キナーゼ阻害剤化合物として有用なアミノトリアジン誘導体 |
| US9994547B2 (en) | 2014-10-06 | 2018-06-12 | Takeda Pharmaceutical Company Limited | Heteroarylamide inhibitors of TBK1 |
| JP6788583B2 (ja) | 2014-10-22 | 2020-11-25 | ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド | 増殖性疾患を処置するためのチアゾリル含有化合物 |
| MA41598A (fr) * | 2015-02-25 | 2018-01-02 | Constellation Pharmaceuticals Inc | Composés thérapeutiques de pyridazine et leurs utilisations |
| JP6775516B2 (ja) | 2015-03-17 | 2020-10-28 | ファイザー・インク | 新奇な３−インドール置換誘導体、医薬組成物、および使用方法 |
| JP2018527336A (ja) | 2015-08-10 | 2018-09-20 | ファイザー・インク | ３−インドール置換誘導体、医薬組成物、および使用方法 |
| CU20180059A7 (es) | 2015-12-17 | 2018-10-04 | Gilead Sciences Inc | Compuestos inhibidores de la quinasa de unión a tank |
| EP3390387B1 (en) | 2015-12-18 | 2021-11-17 | Bayer Pharma Aktiengesellschaft | Heteroarylbenzimidazole compounds |
| WO2017207534A1 (en) | 2016-06-03 | 2017-12-07 | Bayer Pharma Aktiengesellschaft | Substituted heteroarylbenzimidazole compounds |
| US10710980B2 (en) | 2016-07-20 | 2020-07-14 | Novartis Ag | Aminopyridine derivatives and their use as selective ALK-2 inhibitors |
| DE102016113714A1 (de) | 2016-07-26 | 2018-02-01 | Rosa Karl | Transfektionsverfahren mit nicht-viralen Genliefersystemen |
| GB201702947D0 (en) | 2017-02-23 | 2017-04-12 | Domainex Ltd | Novel compounds |
| PE20191788A1 (es) * | 2017-04-27 | 2019-12-24 | Ishihara Sangyo Kaisha | Compuesto de n-(4-piridil)nicotinamida o sal del mismo |
| JP7717065B2 (ja) | 2019-11-22 | 2025-08-01 | インサイト コーポレーション | Ａｌｋ２阻害剤及びｊａｋ２阻害剤を含む併用療法 |
| AU2021292484A1 (en) | 2020-06-16 | 2023-01-19 | Incyte Corporation | ALK2 inhibitors for the treatment of anemia |
| WO2022077034A1 (en) * | 2020-10-09 | 2022-04-14 | Napa Therapeutics Ltd. | Heteroaryl amide inhibitors of cd38 |
| CN116099004B (zh) * | 2022-12-30 | 2024-01-30 | 深圳开悦生命科技有限公司 | Rna解旋酶dhx33抑制剂在制备用于治疗膀胱癌的药物中的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| SE0102439D0 (sv) * | 2001-07-05 | 2001-07-05 | Astrazeneca Ab | New compounds |
| SE0102438D0 (sv) | 2001-07-05 | 2001-07-05 | Astrazeneca Ab | New compounds |
| SE0203752D0 (sv) | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
| SE0203754D0 (sv) | 2002-12-17 | 2002-12-17 | Astrazeneca Ab | New compounds |
| JP2007524682A (ja) * | 2004-02-12 | 2007-08-30 | メルク エンド カムパニー インコーポレーテッド | 代謝調節型グルタミン酸受容体−５の調節物質としてのビピリジルアミド |
| TW200800203A (en) * | 2006-03-08 | 2008-01-01 | Astrazeneca Ab | New use |
| WO2007129044A1 (en) | 2006-05-03 | 2007-11-15 | Astrazeneca Ab | Thiazole derivatives and their use as anti-tumour agents |
| WO2009030890A1 (en) | 2007-09-03 | 2009-03-12 | University Court Of The University Of Dundee | Pyrimidine compounds for the treatment of cancer, septic shock and/or primary open angle glaucoma |
| AU2008315746A1 (en) | 2007-10-25 | 2009-04-30 | Astrazeneca Ab | Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders |
| WO2009122180A1 (en) * | 2008-04-02 | 2009-10-08 | Medical Research Council | Pyrimidine derivatives capable of inhibiting one or more kinases |
| ES2921576T3 (es) * | 2008-12-19 | 2022-08-29 | Vertex Pharma | Compuestos útiles como inhibidores de la quinasa ATR |
| GB0903759D0 (en) | 2009-03-04 | 2009-04-15 | Medical Res Council | Compound |
| US8198285B2 (en) * | 2010-01-19 | 2012-06-12 | Astrazeneca Ab | Pyrazine derivatives |
| BR112013029640A2 (pt) * | 2011-05-23 | 2017-06-13 | Merck Patent Gmbh | derivados de piridina e pirazina |
-
2012
- 2012-04-11 BR BR112013029640A patent/BR112013029640A2/pt active Search and Examination
- 2012-04-11 CN CN201280025133.3A patent/CN103748086B/zh not_active Expired - Fee Related
- 2012-04-11 CA CA2832605A patent/CA2832605C/en active Active
- 2012-04-11 PT PT12715279T patent/PT2714677T/pt unknown
- 2012-04-11 RS RS20181427A patent/RS58015B1/sr unknown
- 2012-04-11 EP EP12715279.1A patent/EP2714677B1/en active Active
- 2012-04-11 KR KR1020137030982A patent/KR101581522B1/ko not_active Expired - Fee Related
- 2012-04-11 EA EA201301302A patent/EA023364B1/ru not_active IP Right Cessation
- 2012-04-11 DK DK12715279.1T patent/DK2714677T3/en active
- 2012-04-11 PL PL12715279T patent/PL2714677T3/pl unknown
- 2012-04-11 SI SI201231465T patent/SI2714677T1/sl unknown
- 2012-04-11 SG SG2013074638A patent/SG194105A1/en unknown
- 2012-04-11 AU AU2012259333A patent/AU2012259333B2/en not_active Ceased
- 2012-04-11 LT LTEP12715279.1T patent/LT2714677T/lt unknown
- 2012-04-11 MX MX2013012979A patent/MX352975B/es active IP Right Grant
- 2012-04-11 WO PCT/US2012/032983 patent/WO2012161877A1/en not_active Ceased
- 2012-04-11 HR HRP20181884TT patent/HRP20181884T1/hr unknown
- 2012-04-11 US US14/118,845 patent/US9273029B2/en not_active Expired - Fee Related
- 2012-04-11 JP JP2014512837A patent/JP6054954B2/ja not_active Expired - Fee Related
- 2012-04-11 ES ES12715279T patent/ES2699256T3/es active Active
-
2013
- 2013-10-04 ZA ZA2013/07429A patent/ZA201307429B/en unknown
- 2013-11-21 IL IL229528A patent/IL229528A/en active IP Right Grant
-
2016
- 2016-06-23 JP JP2016124235A patent/JP2016196492A/ja active Pending
-
2018
- 2018-03-28 JP JP2018061990A patent/JP6763904B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016196492A5 (enExample) | ||
| JP2018115201A5 (enExample) | ||
| JP2014518884A5 (enExample) | ||
| JP7169412B2 (ja) | 抗癌活性及び抗増殖活性を呈する２－アミノピリミジン－６－オン及び類似体 | |
| JP2016513660A5 (enExample) | ||
| JP2016506369A5 (enExample) | ||
| JP2013530176A5 (enExample) | ||
| JP2016521710A5 (enExample) | ||
| RU2015138964A (ru) | Полициклические модуляторы рецептора эстрогена и их применения | |
| JP2016525075A5 (enExample) | ||
| JP2013528204A5 (enExample) | ||
| JP2016535772A5 (enExample) | ||
| HRP20171248T1 (hr) | Amino-supstituirani imidazopiridazini | |
| JP2016540811A5 (enExample) | ||
| JP2013523814A5 (enExample) | ||
| JP2015515961A5 (enExample) | ||
| JP2012505891A5 (enExample) | ||
| JP2009526072A5 (enExample) | ||
| JP2017501237A5 (enExample) | ||
| JP2011525502A5 (enExample) | ||
| JP2016526576A5 (enExample) | ||
| JP2011502956A5 (enExample) | ||
| JP2013523710A5 (enExample) | ||
| JP2014511869A5 (enExample) | ||
| JP2013501720A5 (enExample) |